These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25024355)

  • 41. Treatment of late syphilis with 2.4 million units benzathine penicillin G (BPG): tolerance of single versus divided doses.
    Janier M; Libar E; Bonnet A; Meunier P; Tabet M; Mathourais M; Paterour C; Porcher R
    Sex Transm Dis; 2012 May; 39(5):359-60. PubMed ID: 22504599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tertiary syphilis: tubero-serpiginous and tubero-ulcerous syphilids.
    Jorge LM; da Costa Nery JA; Bernardes Filho F
    Braz J Infect Dis; 2016; 20(3):308-9. PubMed ID: 27026572
    [No Abstract]   [Full Text] [Related]  

  • 43. Erroneous treatment of syphilis with benzyl penicillin in an era with benzathine benzylpenicillin shortages.
    Nieuwenburg S; Rietbergen N; van Zuylen D; Vergunst C; de Vries H
    Sex Transm Infect; 2020 Nov; 96(7):552. PubMed ID: 31974215
    [No Abstract]   [Full Text] [Related]  

  • 44. Nonspecific diffuse alopecia as a single manifestation of syphilis infection: clinical and trichoscopic features.
    Costa MC; Peres AS; Queiróz AJR; Souza Medeiros N; Costa IMC
    Int J Dermatol; 2018 May; 57(5):593-595. PubMed ID: 29336022
    [No Abstract]   [Full Text] [Related]  

  • 45. Alopecia syphilitica diffusa.
    Zink A; Kaliebe K; Spinner CD
    Infection; 2015 Dec; 43(6):783-4. PubMed ID: 25929420
    [No Abstract]   [Full Text] [Related]  

  • 46. Secondary Syphilis Mimicking Giant Cell Arteritis.
    Narayan N; Bennett P; Chan C; Rhodes B
    J Clin Rheumatol; 2020 Jan; 26(1):18-20. PubMed ID: 29561471
    [No Abstract]   [Full Text] [Related]  

  • 47. [Serological cardiolipid development of early syphilis treated with a single injection of benzathine-penicillin of 2,400,000 I.U].
    Sekkat A; Ait Bennasser MI; Benhayoune TS; Derdabi D; Sedrati O; Nejmi S; Baaj A
    Ann Dermatol Venereol; 1983; 110(10):835-8. PubMed ID: 6666927
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Secondary syphilis.
    Pagliarello C; Cortelazzi C; Feliciani C; Di Nuzzo S
    Lancet Infect Dis; 2016 Nov; 16(11):1304. PubMed ID: 27788991
    [No Abstract]   [Full Text] [Related]  

  • 49. Failure of benzathine penicillin in a case of seronegative secondary syphilis in a patient with acquired immunodeficiency syndrome: case report and review of the literature.
    Fowler VG; Maxwell GL; Myers SA; Shea CR; Livengood CN; Prieto VG; Hicks CB
    Arch Dermatol; 2001 Oct; 137(10):1374-6. PubMed ID: 11594871
    [No Abstract]   [Full Text] [Related]  

  • 50. [Late results of treating syphilis patients by a chronically alternating method with bicillins 1, 3 and 6 and their combinations with bismuth preparations].
    Remizov DN; Pavlovskaia VE; Rezaĭkina AV
    Vestn Dermatol Venerol; 1979 Aug; (8):64-8. PubMed ID: 494749
    [No Abstract]   [Full Text] [Related]  

  • 51. An atypical syphilis presentation.
    Cervoni GE; By CC; Wesson SK
    Cutis; 2017 Nov; 100(5):E25-E28. PubMed ID: 29232435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of maternal syphilis in rural South Africa: effect of multiple doses of benzathine penicillin on pregnancy loss.
    Myer L; Abdool Karim SS; Lombard C; Wilkinson D
    Trop Med Int Health; 2004 Nov; 9(11):1216-21. PubMed ID: 15548319
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased knowledge of safe and appropriate penicillin injection after viewing brief instructional video titled "how to inject Bicillin LA".
    Gertler S; Ahrens K; Klausner JD
    Sex Transm Dis; 2009 Mar; 36(3):147-8. PubMed ID: 19174733
    [No Abstract]   [Full Text] [Related]  

  • 54. Early and latent syphilis. Current management.
    Catalano PM; Schragger AH
    Arch Dermatol; 1965 Oct; 92(4):433-5. PubMed ID: 5835338
    [No Abstract]   [Full Text] [Related]  

  • 55. [Venous mesenteric infarction revealing tertiary syphilis].
    Bouomrani S; Kilani I; Nouma H; Neffoussi M; Béji M
    Med Mal Infect; 2013 Feb; 43(2):91-2. PubMed ID: 23473705
    [No Abstract]   [Full Text] [Related]  

  • 56. [Assessment of the congenital syphilis prevention programs].
    Daoud M; Duca E; Onofriescu M; Petrescu Z
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):934-7. PubMed ID: 22046811
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ocular manifestations and treatment of syphilis.
    Kiss S; Damico FM; Young LH
    Semin Ophthalmol; 2005; 20(3):161-7. PubMed ID: 16282150
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Picture of the month. Acquired secondary syphilis.
    Ferran M; Martin-Ezquerra G; Vicente A; Noguera A; Alsina L; Gonzalez-Enseñat MA
    Arch Pediatr Adolesc Med; 2007 Feb; 161(2):199-200. PubMed ID: 17283307
    [No Abstract]   [Full Text] [Related]  

  • 59. Syphilitic chancres of the mouth: three cases.
    Ramoni S; Cusini M; Gaiani F; Crosti C
    Acta Derm Venereol; 2009 Nov; 89(6):648-9. PubMed ID: 19997704
    [No Abstract]   [Full Text] [Related]  

  • 60. Standards for treatment of primary and secondary syphilis.
    Fiumara NJ
    Am Fam Physician; 1983 Feb; 27(2):185-8. PubMed ID: 6829372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.